A commercial modification of an enzyme immunoassay (EIA) (Gonozyme; Abbott Laboratories, North Chicago, Ill.) for detection of Neisseria gonorrhoeae antigens was compared with conventional culturing. Specimens from males and females were collected at a sexually transmitted disease clinic; additional female specimens were collected at an obstetrics and gynecology clinic. EIA sensitivity and specificity for males were 100 and 98.6%, respectively (68 negative, 34 positive, 1 false-positive, and 0 false-negative). EIA sensitivity and specificity for female sexually transmitted disease clinic patients were 74.4 and 95.7%, respectively (66 negative, 29 positive, 3 false-positive, and 10 false-negative) EIA sensitivity and specificity for obstetrics and gynecology clinic patients were 100 and 99.2%, respectively (6 positive, 119 negative, 1 false-positive, and 0 false-negative). In female patients from whom multiple swab specimens were collected, the sequence of specimen collection and subsequent EIA analysis affected sensitivity.
Gonorrhea ranks first among reported communicable diseases in the United States. Efforts to control its spread include screening asymptomatic females in obstetrics and gynecology (ObGyn) clinics and establishing federally subsidized clinics for the diagnosis, treatment, and epidemiological follow-up of individuals with sexually transmitted diseases (STD). Central to these efforts are the accuracy and time required for the laboratory diagnosis of gonococcal infections. Currently, the Centers for Disease Control recommends bacteriological culturing as the definitive method for diagnosing gonorrhea (2) . Presumptive diagnosis of urogenital gonorrhea in males may be made on the basis of Gram staining, and this method is frequently used to identify individuals requiring antigonococcal therapy. With urogenital specimens from females, however, Gram staining is less sensitive than culturing, and its specificity varies with the expertise of the reader (4, 7) . Bacteriological culturing is not an ideal diagnostic modality; it is labor intensive, requires technical competence, takes a minimum of 24 h, and is subject to insensitivity caused by loss of viability associated with improper specimen handling (10, 11) .
An enzyme immunoassay (EIA) (Gonozyme; Abbott Laboratories, North Chicago, Ill.) for detecting antigens of Neisseria gonorrhoeae in urethral (male) or endocervical (female) specimens was recently marketed. It has been evaluated in several laboratories (1, 3, 6, 8, 9) . In an earlier evaluation of this EIA, we found that the sensitivity and specificity exceeded 95% for specimens from males (6) . For endocervical specimens, the sensitivity and specificity of the EIA were 79.2 and 87.2%, respectively (6) . The manufacturer has made several modifications of the product, presumably to improve its validity for endocervical specimens. Our Statistical analysis of EIA absorbance data. The mean absorbances ± standard deviations were determined by standard methods (5) . The absorbances of the first and second swab specimens were compared by using Student's t test (5) .
RESULTS
The EIA results for all three patient populations are shown in Table 1 . For males, the sensitivity, specificity, and positive and negative predictive values all exceeded 97%. For ObGyn clinic patients, the sensitivity and specificity were 100 and 99.2%, respectively. Although the specificity of EIA was 95.7% for female STD clinic patients, the sensitivity was only 74.4%.
To determine whether sequential collection of endocervical swab specimens resulted in differential recovery of N. gonorrhoeae antigens, we compared the absorbances of the two swabs from 26 of the 29 female STD clinic patients with TP EIA results; paired swabs were not available from three patients. Of the 26 paired specimens, 8 were excluded because the quantity of antigen on each of the two swabs equaled or exceeded the amount required for a maximum absorbance. For the remaining 18 paired specimens, the mean absorbances were 1.3 (±0.700 SD) and 0.833 (±0.424 SD) for the first and second endocervical swab specimens, respectively. The difference in absorbances between the two swab specimens was statistically significant (P < 0.025), demonstrating that the first swab specimen contained a greater concentration of antigen than the second.
The number of CFU of N. gonorrhoeae was counted for culture-positive endocervical specimens (Table 2) . Of the 45 culture-positive (TP plus FN) endocervical specimens, 32 had >50 CFU, and 12 had <50 CFU (1 was not counted). Of the 10 specimens yielding FN EIA results, 6 had <50 CFU, and 4 had >50 CFU. Of the 12 culture-positive specimens yielding <50 CFU, 6 (50%) produced a FN EIA result, whereas only 4 of the 32 (12.5%) specimens yielding >50 CFU generated a FN EIA result.
DISCUSSION
The sensitivity (100%) and specificity (98.6%) of EIA for male specimens would suggest that this method be considered as a suitable alternative to culturing for establishing definitive evidence of gonorrhea. For ObGyn clinic patients, EIA also performed well (sensitivity, 100%, specificity, 99.2%). A disadvantage of using EIA or other nonculture methods for diagnosing gonorrhea is that organisms are not available for assessing beta-lactamase production.
The specificity of EIA for specimens from female STD clinic patients was 95.7%. A chart review of the three female STD clinic patients whose specimens yielded FP EIA results revealed that two were asymptomatic and that one had a vaginal discharge of undetermined etiology. None of these three patients had received antibiotics for 1 week before cultures were done.
The sensitivity of EIA for specimens from female STD clinic patients was 74.4%. The sensitivity of a diagnostic test varies inversely with the number of specimens yielding FN results. As shown in Table 2 , specimens yielding <50 CFU were more likely to produce a FN EIA result than specimens yielding >50 CFU. Clearly, the number of organisms recovered on a swab specimen is critical in determining the outcome of EIA. It is also apparent that bacteriological culturing for N. gonorrhoeae has a lower threshold for positivity (theoretically, one viable organism) than does EIA.
It appears that the study protocol, which maximized recovery of viable organisms for culturing and minimized recovery of antigen for EIA, biased results toward the insensitivity of EIA. The 10 specimens yielding FN EIA results were all collected from female STD clinic patients. A FN EIA result in these patients indicated that culturing of the second swab specimen yielded N. gonorrhoeae but that EIA of the same swab specimen was negative. Initially, no more than two procedures were performed on a single swab specimen. This decision stemmed from the manufacturer's impression that two procedures would remove a substantial quantity of antigenic material from the swab. As it is routine procedure at the Erie County Department of Health STD clinic to set up cultures and prepare films for Gram staining for all patients, two swab specimens had to be procured from each STD patient; the first swab specimen was used for culturing and Gram staining, and the second swab specimen was used for culturing and EIA. The first swab specimens from 5 of the 10 patients with FN EIA results were available for EIA. Of these five first swab specimens, three were positive by EIA, one was within the retest range (but was not retested), and one was negative by EIA. Thus, for four of these five patients with FN EIA results, the first swab specimen contained more antigenic material than the second. Similarly, for endocervical specimens yielding TP EIA results, first swab specimens had higher mean spectrophotometric absorbances than second swab specimens, once again This modified EIA is equal to or better than the previously marketed product for diagnosing gonorrhea in males; the sensitivity and specificity both exceeded 98%. Compared with a previously evaluated EIA (6), this product showed increased specificity for endocervical specimens. The sensitivity of the assay remained low for endocervical specimens collected at the STD clinic (74.4%); however, we believe that this value underestimates the true sensitivity of EIA.
